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Abstract 
Despite the substantial evidence that supports the efficacy of cognitive-behavioral 
therapy for the treatment of anxiety and related disorders, our understanding of mechanisms of 
change throughout treatment remains limited. The goal of the current study was to examine 
changes in experiential avoidance across treatment in a sample of participants (N = 179) with 
heterogeneous anxiety disorders receiving various cognitive-behavioral therapy protocols. 
Univariate latent growth curve models were conducted to examine change in experiential 
avoidance across treatment, followed by parallel process latent growth curve models to examine 
the relationship between change in experiential avoidance and change in anxiety symptoms. 
Finally, bivariate latent difference score models were conducted to examine the temporal 
precedence of change in experiential avoidance and change in anxiety. Results indicated that 
there were significant reductions in experiential avoidance across cognitive-behavioral treatment, 
and that change in experiential avoidance was significantly associated with change in anxiety. 
Results from the latent difference score models indicated that change in experiential avoidance 
preceded and predicted subsequent changes in anxiety, whereas change in anxiety did not 
precede and predict subsequent changes in experiential avoidance. Taken together, these results 
provide additional support for reductions in experiential avoidance as a transdiagnostic 
mechanism in cognitive-behavioral therapy.  
  
 
 
Keywords: experiential avoidance; mechanism of change; transdiagnostic; cognitive behavioral 
therapy; latent difference score 
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 Although substantial evidence supports the efficacy of cognitive-behavioral therapy 
(CBT) for the treatment of emotional disorders, including anxiety disorders and depression 
(Butler, Chapman, Forman, & Beck, 2006; Hofmann & Smits, 2008), the mechanisms through 
which successful interventions exert their effects remain less understood (Kazdin, 2007). A more 
in depth understanding of why and how different treatment modalities work has important 
implications for the optimization, personalization, and dissemination of effective psychological 
treatments (Kazdin, 2007). Additionally, adopting a mechanistic approach to evaluating the 
effectiveness of different treatments provides a common framework to distill the “active 
ingredients” that underlie changes in symptoms across protocols. In fact, while various treatment 
approaches exist within the umbrella of CBT, each targeting specific psychopathological 
populations (Barlow, Allen, & Choate, 2004), it is likely that the majority of these interventions 
share common mechanisms of change (Kazdin, 2007).  
Experiential avoidance (EA) is a psychological process that has long been posited to play 
a significant role in the etiology and maintenance of a range of mental health conditions (Hayes 
et al., 1999; Hayes, Wilson, Gifford, Follette, & Strosahl, 1996). EA is defined as an 
unwillingness to experience uncomfortable or distressing physical sensations, thoughts, or 
emotions, coupled with subsequent attempts to escape or avoid such experiences, despite 
unfavorable long-term consequences (Chawla & Ostafin, 2007; Hayes et al., 1996; Rochefort, 
Baldwin, & Chmielewski, 2018). Although occasional avoidance of unwanted internal 
experiences can be an adaptive emotion regulation strategy in the short-term, the resultant relief 
from distress can be reinforcing, leading to an enduring, rigid, and maladaptive pattern of EA 
(Hayes et al., 1996). Paradoxically, attempts to avoid or control distressing internal experiences 
have been shown to increase the frequency of the experience and the distress associated with it 
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(e.g. Roemer & Borkovec, 1994; Wegner, Schneider, Carter, & White, 1987). Therefore, use of 
EA can maintain and increase symptoms of anxiety and related disorders. EA can include a wide 
range of attempts to control or alter various distressing internal experiences including physical 
sensations, thoughts, and emotions, and can also manifest behaviorally (e.g., avoiding situations 
that might lead to a strong emotion). Previous research suggests that different manifestations of 
EA may differentially predict anxiety and depression (Blalock & Joiner, 2000). However, 
regardless of the specific form, the various manifestations of EA serve the same function- to 
attempt to avoid or alter unwanted distressing internal experiences.  
EA has been implicated as a vulnerability factor in various types of psychopathology, 
with particularly substantial evidence for its association with anxiety and depressive disorders 
(Naragon-Gainey & Watson, 2018). Additionally, lower levels of EA have been associated with 
reduced PTSD symptoms following a traumatic experience in samples of college students and  
veterans with PTSD and related impairments (Meyer et al., 2019; Orcutt, Pickett, & Pope, 2005). 
Finally, in a non-clinical sample, EA mediated the relations between worry and several 
constructs that are also associated with the development of emotional disorders (intolerance of 
uncertainty, metacognitive beliefs, and negative emotional schemas; Akbari & Khanipour, 2018). 
EA has also been associated with the maintenance of anxiety and depressive disorders. 
Specifically, one recent study found that EA uniquely predicted the maintenance of anxiety 
disorders over and above neuroticism, rumination, and worry in a sample of adults with current 
or past anxiety disorders (Spinhoven, van Hemert, & Penninx, 2017). In addition, EA has been 
associated with the maintenance of additional emotional disorders including obsessive-
compulsive disorder (OCD), and post-traumatic stress disorder (PTSD), along with related 
maladaptive behaviors that function to avoid strong emotions such as substance use and 
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suicidality (Hayes et al., 1996). Taken together, EA appears to be a transdiagnostic process that 
is relevant to the range of anxiety, depressive, and related disorders (Hayes et al., 1996; 
Naragon-Gainey & Watson, 2018). 
EA has received increased attention as a treatment target for emotional disorders (Gámez, 
Chmielewski, Kotov, Ruggero, & Watson, 2011) given its role as a psychopathological process 
that contributes to the development and maintenance of these conditions. In fact, EA is central to 
mindfulness and acceptance-based behavioral conceptual models and treatments, which include a 
focus on altering how individuals respond to their internal experiences (e.g., emotions, thoughts, 
physical sensations) through decreasing EA and increasing acceptance (e.g., Hayes, Strosahl, & 
Wilson, 2011; Roemer & Orsillo, 2009, 2014). Emotional avoidance is also a target in other CBT 
approaches (e.g., Barlow et al., 2018). 
Previous research has demonstrated significant reductions in EA following treatment with 
mindfulness and acceptance-based behavioral interventions, as well as more traditional CBT 
approaches, across samples with heterogeneous anxiety disorders (Arch, Wolitzky-Taylor, Eifert, 
& Craske, 2012; Ciarrochi, Bilich, & Godsell, 2010; Roemer, Orsillo, & Salters-Pedneault, 
2008). Moreover, change in EA is related to change in treatment outcomes. For example, in a 
trial of acceptance and commitment therapy (ACT; Dalrymple & Herbert, 2007), early change in 
EA predicted later improvements in symptom severity for participants with social anxiety 
disorder; a similar pattern of results was observed during treatment with mindfulness and 
acceptance-based group therapy (Kocovski, Fleming, & Rector, 2009). In addition, reductions in 
EA mediated change in symptom outcome and quality of life during acceptance-based behavior 
therapy and applied relaxation in a sample of participants with generalized anxiety disorder 
(Eustis, Hayes-Skelton, Roemer, & Orsillo, 2016). Kocovski and colleagues (2015) utilized 
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rigorous latent difference score analyses in a sample of participants with social anxiety disorder 
who received either mindfulness and acceptance-based group therapy or traditional CBT to 
examine acceptance (sometimes referred to as the opposite of EA), but the authors reported that 
the LDS results for acceptance did not indicate one clear model with better fit, and should be 
interpreted with caution, limiting the conclusions that can be drawn. Finally, Espejo, Gorlick, 
and Castriotta (2017) found that reductions in EA mediated decreases in negative affect and fear 
ratings in a sample of 48 veterans receiving transdiagnostic group CBT. The results from these 
studies indicate that EA decreases significantly across treatment for emotional disorders, and that 
change in EA is often significantly associated with outcomes. Despite the existing research 
support for EA as a hypothesized mechanism of change in CBT, several previous studies relied 
on open trial designs and were limited by small sample sizes, and the majority did not utilize 
statistical analyses that satisfy the requirements for full temporal precedence.                                                                                                                       
Kazdin (2007) puts forth seven criteria to establish variables as mechanisms or mediators: 
1) strong association, 2) specificity, 3) consistency, 4) experimental manipulation, 5) timeline, 6) 
gradient, and 7) plausibility, and notes that no single study can cover all of these requirements 
given their scope. The existing literature has demonstrated a strong association between 
reductions in EA and treatment outcome, and these results have been replicated across a range of 
CBT interventions and studies (consistency). In addition, there is a theoretical explanation 
(plausibility) for how reductions in EA lead to improvements in outcomes both in the literature 
on mindfulness and acceptance-based behavioral therapies as well as more traditional CBTs 
(e.g., Arch & Craske, 2008; Hayes, Pistorello, & Levin, 2012; Hayes-Skelton, Usmani, Lee, 
Roemer, & Orsillo, 2012; Roemer & Orsillo, 2009, 2014). However, as described previously, 
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research on the temporal precedence of change in EA and change in outcomes is lacking 
(timeline).  
EA has been conceptualized as both a global construct (i.e., single-factor) as well as a 
multidimensional construct. The Acceptance and Action Questionnaire (AAQ; Hayes et al., 
2004) and its revised version (AAQ-II; Bond et al., 2011) are the most widely used measures of 
EA to date. The original version of the AAQ measures two aspects of EA: 1) non-acceptance of 
distress and 2) interference of avoidance with valued actions (or personally meaningful actions). 
Unfortunately, the original AAQ has demonstrated suboptimal internal consistency (Hayes et al., 
2004; Rochefort et al., 2018).  
The AAQ-II (single factor) was developed in response to psychometric concerns with the 
original AAQ, and yields better internal consistency relative to the original AAQ; unfortunately, 
it continues to demonstrate suboptimal construct validity with measures of neuroticism, negative 
affect, and mindfulness (Rochefort et al., 2018). Specifically, the AAQ-II appears to be a 
stronger measure of an individual’s perceived distress (or negative affect) than of an individual’s 
response to distress (Wolgast, 2014). Additionally, more recently, the AAQ has been described 
in the literature as a measure of psychological inflexibility, a broader term referring to the six 
key targets within ACT (Gámez et al., 2011; Hayes et al., 2012, 2004), suggesting that it may not 
be a pure measure of EA. 
A relatively newer and understudied alternative to the AAQ and AAQ-II is the 
Multidimensional Experiential Avoidance Questionnaire (MEAQ; Gámez et al., 2011). The 
MEAQ is a 62-item, multidimensional self-report measure designed to both address the 
psychometric limitations of the AAQ and AAQ-II, and to distinguish EA from higher order 
personality traits like negative affectivity. This measure assesses EA as a trait-like tendency and 
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attempts to capture extreme, pervasive manifestations of EA. Cross-validation studies of the 
MEAQ have demonstrated good internal consistency, optimal convergent validity with measures 
of avoidance, and adequate discriminant validity from neuroticism (see Measures for additional 
detail; Gámez et al., 2011; Rochefort et al., 2018). Based on these findings, Rochefort and 
colleagues (2018) recommend using the MEAQ to assess EA over other available self-report 
measures. Although the MEAQ includes six subscales (see Method), distress aversion - defined 
as “negative evaluations or attitudes toward distress” and attempts to avoid emotional distress - 
(Gámez et al., 2011) – is believed to be core to the construct of EA, and has demonstrated one of 
the highest factor loadings out of the subscales in initial studies (Gámez et al., 2011).  
With the exception of one idiographic single case study that examined change on the 
distraction/suppression subscale of the MEAQ (Boswell, Anderson, & Barlow, 2014), the 
MEAQ has not been used to examine changes in EA during treatment. Thus, the current study 
has three main goals. First, we aimed to examine whether there were significant reductions in the 
MEAQ total score, and the distress aversion subscale of the MEAQ, during a course of CBT. 
Given the absence of research utilizing the MEAQ in treatment outcome research we decided to 
examine both the MEAQ total score and the distress aversion subscale, as this subscale has been 
identified as core to the construct of EA. We hypothesized that there would be significant 
reductions in both the MEAQ total score and the distress aversion subscale across treatment. The 
second aim was to examine whether change in EA was associated with change in treatment 
outcome (symptoms of anxiety); we hypothesized that change in EA would be significantly 
associated with change in symptoms of anxiety. The third aim, which was exploratory and 
consistent with Kazdin’s timeline criteria for mechanisms, sought to examine whether change in 
EA preceded and predicted subsequent change in symptoms of anxiety.  
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Method 
Procedure 
 The study was approved by the Institutional Review Board at Boston University. The 
current study is a secondary data analysis from a randomized controlled equivalence trial 
comparing five CBT protocols (described below) and a waitlist control condition in a sample of 
participants with heterogeneous principal anxiety disorders. Given the existing literature that 
indicates that change in EA occurs across a range of treatments that fall under the CBT umbrella 
(e.g., Eustis et al., 2016), and our aim to explore the role of EA as a mechanism of change in 
CBT, the active treatment conditions (i.e., all five CBT protocols) were collapsed into a single 
sample and waitlist participants were excluded. Additional details about the parent study, 
including participant flow, have been previously reported (please see Barlow et al., 2017). 
Participants  
The current study includes 179 participants who were randomized to active CBT 
treatment conditions in the parent study (Barlow et al., 2017). Participants were recruited from 
the Center for Anxiety and Related Disorders at Boston University. Inclusion criteria required 
that eligible individuals were assigned a principal diagnosis of panic disorder with or without 
agoraphobia (PD/A; n = 47), generalized anxiety disorder (GAD; n = 49), social anxiety disorder 
(SAD; n = 48), or obsessive-compulsive disorder (OCD; n = 35) using the Anxiety Disorder 
Interview Schedule (ADIS; Brown & Barlow, 2014; Brown, DiNardo, & Barlow, 1994), were 18 
years of age or older, and fluent in English. There were no exclusions based on emotional 
disorder comorbidity. The majority of participants (83.2%) identified racially as White, while 
7.3% identified as Black, 6.7% as Asian, 0.6% as Native Hawaiian or Pacific Islander, and 2.2% 
as Multiracial. In terms of ethnicity, 8.4 % identified as Hispanic/Latinx, while 91.6% identified 
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as non-Hispanic/Latinx. The majority of the sample identified their biological sex as female 
(55.3%), with 44.7% identifying their biological sex as male. Finally, the mean age of the sample 
was 30.66 years (SD = 10.77).  
CBT Interventions 
 Participants were randomized to either the waitlist control condition or to one of two 
active treatment conditions, the Unified Protocol for Transdiagnostic Treatment of Emotional 
Disorders or Single Disorder Protocols (block randomization with a 1:2:2 allocation ratio, 
respectively). The Unified Protocol (Barlow et al., 2018) is a transdiagnostic cognitive-
behavioral intervention that was developed to target emotional disorders (e.g., anxiety, 
depressive, and related disorders). This protocol includes five core modules aimed at decreasing 
aversive, avoidant responses to emotional experiences: mindful emotion awareness, cognitive 
flexibility, countering emotional behaviors, understanding and confronting physical sensations, 
and emotion exposures. Previous research supports the efficacy of the Unified Protocol in 
treating heterogeneous anxiety and related emotional disorders (Barlow et al., 2017; Barlow & 
Farchione, 2018; Farchione et al., 2012).  
 The single disorder protocols included in the current study were Managing Social 
Anxiety: A Cognitive Behavioral Therapy Approach, second edition (Hope, Heimberg, & Turk, 
2006, 2010) for SAD, Mastery of Your Anxiety and Panic, fourth edition (Barlow & Craske, 
2006; Craske & Barlow, 2007), for PD/A, Mastery of Your Anxiety and Worry, second edition 
(Craske & Barlow, 2006; Zinbarg, Craske, & Barlow, 2006) for GAD, and Treating Your 
Obsessive-Compulsive Disorder With Exposure and Response (Ritual) Prevention Therapy, 
second edition (Foa, Yadin, & Lichner, 2012a; Foa, Yadin, & Lichner, 2012b) for OCD.  
Running Head: Experiential Avoidance in CBT  11 
 
Measures 
The Multidimensional Experiential Avoidance Questionnaire (MEAQ; Gámez et al., 
2011) is a 62-item self-report measure of experiential avoidance. The MEAQ yields a total score 
and six subscales: distress aversion, behavioral avoidance, procrastination, 
distraction/suppression, repression/denial, and distress endurance. In addition to being 
hypothesized to tap into one of the core aspects of EA, the distress aversion subscale (DA) had 
one of the strongest factor loadings (compared to the other subscales) on a higher-order 
dimension of EA (Gámez et al., 2011), and has been utilized in previous research examining EA 
(Naragon-Gainey & Watson, 2018). For both the MEAQ total score and the distress aversion 
subscale score higher scores indicate higher levels of EA and distress aversion, respectively. The 
MEAQ has evidenced stronger discriminatory validity with constructs such as neuroticism and 
negative affect compared to previous measures of EA (e.g., MEAQ & NA: r = .54, MEAQ-DA 
& NA: r = .41, AAQ-II & NA: r = .74; Gámez et al., 2011). Rochefort and colleagues (2018) 
examined the convergent and discriminant validity of the MEAQ and AAQ-II with 
neuroticism/negative affect and reported that the AAQ-II was more strongly correlated with 
measures of neuroticism/negative affect (rs = .59-.71), whereas correlations between the MEAQ 
and neuroticism/negative affect were between .44-.57. With regard to convergent validity, they 
reported that the MEAQ was more strongly correlated with other mindfulness and acceptance-
based constructs (e.g., mindfulness) as would be expected, whereas the AAQ-II was more 
strongly correlated with neuroticism/negative affect than it was with mindfulness and 
acceptance-based constructs. In addition, the total score and distress aversion subscale of the 
MEAQ have demonstrated good-excellent internal reliability across clinical, community, and 
student samples (MEAQ total score a range = .92-.95, MEAQ-DA a range = .84-.89; Gámez et 
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al., 2011). Internal reliability in the current sample at pre-treatment was a = .87 for the total 
score, and a = .88 for the distress aversion subscale. Taken together, these results suggest that 
the MEAQ has stronger psychometric properties than previous measures of EA. Therefore, we 
utilized the MEAQ total score and the MEAQ distress aversion subscale in the current study.  
The Hamilton Anxiety Scale (HAS; Hamilton, 1959) is a gold standard measure of 
symptoms of anxiety that has demonstrated good reliability and validity (Shear et al., 2001). In 
addition, the HAS has been used as an outcome measure in recent transdiagnostic treatment 
research (Barlow et al., 2017). Higher scores on the HAS indicate higher levels of anxiety. In the 
current study, this measure was administered by independent evaluators who were blind to 
treatment condition following the Structured Interview Guide for the Hamilton Anxiety (SIGH-
A; Shear et al., 2001). Internal reliability in the current sample at pre-treatment was a = .83.  
Data Analytic Plan 
All analyses were conducted on the raw data using Mplus version 7 (Muthén & Muthén, 
1998) and robust maximum likelihood estimation (MLR) to account for non-normal and missing 
data. To examine our first aim, a series of univariate latent growth curve models (LGMs) were 
estimated to examine change in EA (MEAQ total score and MEAQ distress aversion subscale) 
and symptoms of anxiety across treatment. The MEAQ and HAS were administered every four 
sessions (five time points: pre-treatment, session 4, session 8, session 12, and post-treatment), 
roughly every four weeks. Univariate LGMs were conducted for each measure to determine: 1) 
whether the sample (on average) experienced significant reductions in EA and anxiety symptoms 
across treatment (i.e., latent slope mean) and 2) whether there were significant individual 
differences in trajectories of change in EA and anxiety symptoms across participants (i.e., latent 
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slope variance). Slope factors were justified by fixing the factor loadings for the pre-treatment 
and post-treatment assessments to 0 and 1, respectively, and freely estimating the slope loadings 
at sessions 4, 8, and 12. This specification permits modeling of nonlinear trajectories in EA and 
anxiety symptoms over the course of treatment. Latent intercepts were fixed to 1 (i.e., pre-
treatment value).  
After estimating the univariate LGMs, two parallel process LGMs were estimated to 
examine the associations between change in EA and change in symptoms of anxiety over 
treatment (i.e., MEAQ total score and HAS; MEAQ-DA and HAS). Residual covariances 
between the measures at each assessment (e.g., HAS scores at session 4 with MEAQ total score 
at session 4) were specified to capture time-specific covariance. In all LGMs, associations 
between the latent intercept and slope factors were freely estimated. Model fit was evaluated 
using root-mean-square-error of approximation (RMSEA; Steiger, 1990), the Tucker-Lewis 
Index (TLI; Tucker & Lewis, 1973), and the comparative fit index (CFI; Bentler, 1990). 
Standard model fit criteria were used to determine adequate model fit (RMSEA close to or < .06, 
CFI and TLI values > .95). The acceptability of the models was further evaluated by the presence 
or absence of salient localized areas of strain in the solutions (e.g., modification indices), and the 
strength and interpretability of the parameter estimates. 
For our final and exploratory aim, we conducted a series of bivariate latent difference 
score models (LDS; Ferrer & McArdle, 2003) to examine the temporal precedence of within-
participant changes in EA and anxiety symptoms, and distress aversion and anxiety symptoms. 
LDS analyses combine aspects of latent growth curve modeling, cross-lagged regression 
analyses, and latent difference score analyses (McArdle & Nesselroade, 1994). These models 
examine the latent changes on variables across multiple time points, and test whether change in 
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one variable precedes and predicts change in another variable using a coupling parameter γ.  
Following convention (Ferrer & McArdle, 2003), four competing coupling parameter 
specifications were evaluated. LDS models were first estimated for MEAQ total score and 
anxiety, and subsequently for the MEAQ distress aversion subscale and anxiety. The first model 
specified reciprocal prediction of EA and anxiety across time points (e.g., EA àHAS and HAS 
àEA; “both coupling”; see Figure 1), the second specified EA predicting anxiety only 
(EAàHAS), the third specified anxiety predicting EA only (HAS à EA), and the fourth omitted 
the coupling parameter (no coupling). The Satorra-Bentler calculation for scaled chi-square 
difference values when using MLR was utilized to compare model fit across these four models. 
Given that participants in the parent trial who received a principal diagnosis of PDA/PD received 
12 sessions of treatment and all other participants received 16 sessions of treatment1, we 
conducted the LDS analyses with the participants in the active CBT conditions with a principal 
diagnosis of SAD, GAD, or OCD (n = 164), and excluded participants with principal PDA/PD in 
order to examine changes and timing across an equal number of treatment sessions.  
Results 
Univariate Latent Growth Models  
Means and standard deviations for study variables are presented in Table 1. Results from 
the three univariate LGMs, all of which provided acceptable model fit, can be found in Table 2. 
The univariate LGMs examining changes in MEAQ total score, MEAQ-DA, and HAS across 
treatment in the sample of participants who received CBT indicated that there were significant 
 
1 Number of treatment sessions in the Unified Protocol condition were based on the 
recommended number of sessions in each SDP to control for number of sessions across active 
treatment conditions.  
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reductions (on average) in EA and anxiety symptoms (MEAQ total score slope mean = -34.01, p 
< .001; MEAQ-DA slope mean = -9.78, p < .001; HAS slope mean = -7.59, p < .001) and 
significant individual differences in trajectories of change for these constructs (MEAQ total 
score slope variance = 958.27, p < .001; MEAQ-DA slope variance = 71.78, p < .001; HAS slope 
variance = 36.07, p < .001).2 The univariate slope factor loadings indicate that most of the 
change (reductions) in MEAQ-DA occurred over the first eight sessions (session 4 and 8 factor 
loadings = 0.35 and 0.79, respectively, i.e., 35% of the reduction in MEAQ-DA occurred by 
session 4 and 79% by mid-treatment). In comparison, a smaller proportion of the change in 
MEAQ total score and HAS occurred by mid-treatment (session 8 factor loading = 0.57 for 
MEAQ total score and 0.55 for HAS). 
Association Between EA and Anxiety Outcomes 
 Parallel process LGMs were conducted to examine the associations between change in 
EA and change in symptoms of anxiety across treatment (Model 1: MEAQ total score and HAS; 
Model 2: MEAQ-DA and HAS). Both models provided acceptable model fit (Table 3). The 
completely standardized correlations among the latent variables indicated that change in MEAQ 
total score (completely standardized r = .68, p < .001) and MEAQ-DA (completely standardized 
r = .57, p < .001) were each significantly associated with change in HAS, with decreases in EA 
across treatment being significantly associated with decreases in symptoms of anxiety.  
Latent Difference Score Models  
 
2 Additional univariate LGMs examined reductions in EA (MEAQ total score and MEAQ-DA 
subscale) within the Unified Protocol and Single Disorder Protocol conditions separately, and 
indicated that there were significant reductions in EA (MEAQ total score and MEAQ-DA) 
within each treatment condition, and no significant differences between the Unified Protocol and 
Single Disorder Protocol conditions.  
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Since previous analyses indicated that there were significant reductions in EA across 
treatment, and that change in EA was significantly associated with change in symptoms of 
anxiety, we wanted to evaluate the temporal precedence of changes in EA and anxiety using LDS 
modeling. These models were considered to be exploratory because the MEAQ and HAS were 
administered every four sessions opposed to every session (which would have permitted a finer-
grained/session-by-session evaluation of concurrent change in EA and anxiety symptoms; cf. 
Gallagher et al., 2013). However, there is a precedent in the literature to use LDS analyses with 
four to five assessment time points (e.g. Kocovski et al., 2009; Hayes-Skelton et al., 2015). The 
first set of LDS analyses examined the MEAQ total score and HAS. MEAQ and HAS scores 
were standardized to foster LDS model convergence (i.e., due to large differences in score 
ranges/variances). However, in the initial LDS “both coupling” model for the MEAQ total score 
and HAS the coupling parameter from MEAQàanxiety was not significant (estimate = 0.29, p = 
.27), indicating that change in MEAQ total score did not precede and predict subsequent change 
in HAS. The coupling parameter from anxietyàMEAQ was also not significant (estimate = -
0.07, p = .88). Based on these results, additional examination of model fit across the various 
models including the MEAQ total score and the HAS was not warranted. The second set of LDS 
analyses examined the MEAQ-DA subscale and HAS. See Table 4 for results. The bidirectional 
change model, which included pathways from distress aversion (DA) to anxiety and anxiety to 
DA (both coupling) yielded acceptable model fit. The coupling parameter from DAàanxiety 
was significant, indicating that change in MEAQ-DA preceded and predicted change in anxiety 
at the subsequent time point (estimate = 0.30, p = .01), while change in anxiety did not precede 
and predict change in EA (based on the coupling parameter from anxietyàDA; estimate = -0.33, 
p = .28). Next, the DA only model was run. The coupling parameter for DA preceding and 
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predicting anxiety remained significant in this model (estimate = 0.26, p = .02). The second 
model fit was compared to the first model, and the non-significant Satorra-Bentler scaled chi-
square difference test (p = .28) indicates that removing the pathways from anxietyàDA did not 
significantly degrade the model fit, and that the pathways from anxietyàDA can be dropped. 
Model 3 tested the pathway from anxietyà DA only (estimate = -0.40 , p = .47). This model was 
then compared to model 1. The significant Satorra-Bentler scaled chi-square difference test (p = 
.004) indicates that removing the DA pathway significantly degraded the model fit. Finally, the 
fourth model was run with no coupling and compared to the first model, and then the second 
model. The Satorra-Bentler scaled chi-square difference test was significant at a trend level when 
comparing model 4 to model 1 (p = .08) indicating that removing both pathways degraded the 
model at a trend level compared to the both coupling model. When comparing model 4 to model 
2, the Satorra-Bentler scaled chi-square difference test was significant (p = < .01), indicating that 
removing the pathways from DA to anxiety significantly degraded the model. Taken together, 
these results provide preliminary support that changes in DA precede and predict subsequent 
changes in symptoms of anxiety.  
Discussion 
 The purpose of the present study was to add to the growing literature supporting EA as an 
important psychopathological process that can serve as a mechanism of action during cognitive 
behavioral treatments for a range of conditions. Results suggest that, during a course of CBT for 
heterogeneous anxiety disorders, EA and anxiety symptoms decrease significantly, with most of 
the improvement on these targets occurring in the first half of treatment. Of note, approximately 
80% of the change on the MEAQ distress aversion subscale (established as the core element of 
this construct) occurred in the first half of treatment, whereas only 57% of change on the MEAQ 
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total score and 55% of change on the HAS occurred by mid-treatment. These results suggest that 
the distress aversion subscale may change earlier in treatment than MEAQ total score and 
anxiety symptoms. In general, the first half of treatment in the CBT interventions examined in 
the current study focus mostly on psychoeducation, cognitive interventions, and other skills (e.g., 
mindful emotion awareness, diaphragmatic breathing, progressive muscle relaxation, etc.), while 
the second half of these interventions tend to focus more on behavior change and situational 
exposures. It is possible that the distress aversion subscale changes earlier in treatment, as 
participants’ understanding of and responses to their emotions begin to change, and that other 
MEAQ subscales, such as behavioral avoidance, may change later in treatment when there is a 
stronger focus on behavior change. However, additional research is needed to examine these 
questions empirically. In addition, there is variation across the CBT protocols utilized in the 
current study, and the SDP for OCD introduces exposure and response prevention earlier in 
treatment. Future research should examine if reductions in EA are associated with specific CBT 
treatment components. To our knowledge no other studies to date have examined change on the 
MEAQ or distress aversion subscale across treatment, with the exception of one single case 
study that examined the distraction/suppression MEAQ subscale (Boswell et al., 2014). The 
finding that there were significant reductions in EA across treatment is consistent with the 
existing literature (Arch et al., 2012; Roemer et al., 2008). Furthermore, parallel process LGMs 
revealed that change in EA, assessed via the MEAQ total score and its distress aversion subscale, 
was significantly associated with change in anxiety symptoms. These findings are in line with 
the existing literature that indicates that change in EA is associated with change in outcomes 
(Dalrymple & Herbert, 2007; Kocovski et al., 2009). With regard to baseline scores, results 
indicated that higher MEAQ total scores were significantly associated with higher levels of 
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anxiety symptoms at pre-treatment. However, baseline MEAQ distress aversion scores were not 
significantly associated with baseline symptoms of anxiety. This was unexpected, as in general, 
research has found that higher levels of EA are associated with higher symptoms of anxiety 
(Hayes et al., 2004; Naragon-Gainey & Watson, 2018). Given that the MEAQ is a relatively 
newer measure, additional research is warranted to examine whether this result is replicated in 
other samples. Finally, in order to establish the temporal precedence necessary to meet Kazdin’s 
timeline criteria for mechanisms of change (Kazdin, 2007), LDS analyses were used to explore 
whether improvements in EA preceded and predicted subsequent decreases in anxiety symptoms. 
Results from the LDS models examining the MEAQ total score and anxiety indicated that 
change in MEAQ total score did not precede and predict change in anxiety symptoms. However, 
our findings from the LDS models examining the distress aversion subscale of the MEAQ 
suggest that change on this subscale preceded and predicted change in anxiety symptoms. When 
the impact of anxiety on EA broadly (MEAQ total score) and the distress aversion subscale were 
examined, the results indicated that change in anxiety did not precede or predict change in EA, 
which provides additional support for EA as a mechanism of change. The results from the LDS 
models provide a unique contribution to the literature by building off of existing research that 
has found reductions in EA to be a mediator of outcomes (Espejo et al., 2017; Eustis et al., 2016) 
by examining the full temporal precedence of change in EA and change in anxiety. One other 
study utilized LDS analyses to examine change in acceptance (sometimes referred to as the 
opposite of EA) in a sample of participants with social anxiety disorder, but the results from 
these models were inconclusive (Kocovski et al., 2015). 
The findings from the present study represent an important contribution to our field’s 
understanding of how CBT, long established as efficacious for symptom reduction in anxiety 
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disorders (Hofmann & Smits, 2008), exerts its effects. The goals of this study, to identify 
whether EA drives symptom improvement during treatment, are consistent with recent efforts to 
develop more potent interventions by only including elements that lead to therapeutic change 
(e.g., the National Institute of Mental Health’s Research Domain Criteria). Understanding the 
key processes that change during treatment, along with their effect on symptoms, may allow 
treatment developers to create interventions that include only active treatment components (i.e., 
skills) that target these mechanisms more directly. Given that all of the CBT protocols used in 
the present study consist of multiple components, future research should explore whether all 
skills included in these treatment packages each contribute to reductions in EA. 
 Additionally, much of the previous research exploring the role of EA in the context of 
treatment outcome research has used the AAQ or AAQ-II to assess this construct. Given the 
psychometric limitations of these measures, it is not surprising that the literature has been 
somewhat mixed with regard to the relationship between EA and other psychopathological 
processes. The present study, in contrast, used the MEAQ, a newly developed assessment tool 
that has evidenced strong psychometric properties and demonstrates that EA is a distinguishable  
construct from other risk-conferring transdiagnostic process (e.g., negative affectivity; Gámez et 
al., 2011). To our knowledge, the present study represents the first large-scale examination of the 
MEAQ in the context of a treatment outcome study. Furthermore, using a psychometrically 
sound measure of this construct allows for greater confidence in our finding that the distress 
aversion subscale of the MEAQ is a treatment mechanism for CBT. However, we found 
significant differences in results between the DA subscale and MEAQ total score both in the 
timing of change across treatment and the temporal relationship between change in these 
variables and change in anxiety. These differences in results raise questions about the utility of 
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the MEAQ total score above and beyond the distress aversion subscale, at least in the current 
sample. Previous research has conceptualized the distress aversion subscale as central to the 
construct of EA and this subscale had one of the strongest factor loadings in initial tests, and has 
been used in previous research (Gámez et al., 2011; Naragon-Gainey & Watson, 2018). This 
subscale focuses on individuals’ negative evaluations of their distress (i.e. “non-acceptance of 
distress”; Gámez et al., 2011); changing evaluations of and reactions to emotions is consistent 
with conceptual models of mindfulness and acceptance-based behavioral therapies (e.g., Hayes et 
al., 2012; Roemer et al., 2009, 2014), and the functional model of emotional disorders in the 
Unified Protocol (Barlow et al., 2018), one of the CBT protocols utilized in the current study. In 
addition, previous research has suggested that reductions in EA and increases in acceptance of 
emotions also occur in traditional CBTs that may not emphasize these constructs as explicitly as 
mindfulness and acceptance-based CBTs (Arch & Craske, 2008; Eustis et al., 2016; Hayes-
Skelton et al., 2012). Additional research is needed to examine the MEAQ total score and the 
other subscales across treatment, and to see whether or not our results are replicated. In line with 
Kazdin’s criteria of specificity, future research is needed to investigate the relations among 
various mechanisms of change in CBTs. For example, there are a number of constructs or 
mechanisms of change in the literature, mostly related to specific mental health disorders, that 
may have some overlap with EA (e.g., anxiety sensitivity, intolerance of uncertainty). This is an 
important area for future research. Future research should also continue to examine the relations 
among EA, NA, and neuroticism.  
 The findings of the present study must, of course, be interpreted in the context of its 
limitations. First, assessment of study variables occurred following every four sessions; weekly 
measure of EA and anxiety symptoms would have allowed for a more fine-grained 
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understanding of the timing of improvements. Additionally, although the sample size was quite 
large overall and allowed for sophisticated data analytic techniques to establish temporal 
precedence of EA’s effect on anxiety symptoms during CBT, we were unable to explore 
differential effects as a function of the 5 unique CBT protocols utilized. Additionally, one of the 
latent difference score analyses comparing fit across the various models was significant at a trend 
level, suggesting that our results will need to be replicated and should be interpreted with 
caution. The current study used the Hamilton Anxiety Scale administered by independent 
evaluators as a symptom outcome measure, which is a gold standard measure of anxiety 
symptoms, and has been used previously to assess transdiagnostic symptoms of anxiety (Barlow 
et al., 2017). However, this measure may not be as sensitive to symptoms of some anxiety or 
related disorders (for example, OCD) as others. Future research should also include the use of 
multiple symptom outcome measures to examine replication. Finally, the current study did not 
include a non-CBT intervention condition, so we are not able to examine possible differences in 
reductions in EA between CBT treatment and non-CBT treatment.  
Conclusions  
 Understanding mechanisms of action is an important component of treatment outcome 
research given that knowledge of how interventions exert their effects can inform refinements 
that support treatment potency and efficiency. Using psychometrically sound measures, the 
present study contributes to the growing literature suggesting that experiential avoidance is a 
transdiagnostic psychopathological processes that can be addressed in treatment, and may 
account for symptom improvements during CBT. 
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Table 1 
Means and standard deviations of study variables in the collapsed CBT sample 
Measure Pre-tx Session 4 Session 8 Session 12 Post-tx 
MEAQ-Total 214.56 (32.67) 210.64 (33.87) 196.47 (36.23) 186.43 (39.50) 182.55 (38.44) 
MEAQ-DA 49.20 (11.34) 46.16 (11.91) 41.61 (12.81) 40.13 (13.12) 39.89 (13.13) 
HAS 17.03 (9.05) 16.05 (7.95) 13.10 (7.39) 11.53 (7.48) 8.93 (6.31) 
Note. MEAQ-Total = Multidimensional Experiential Avoidance Questionnaire total score; 
MEAQ-DA = Multidimensional Experiential Avoidance Questionnaire distress aversion 
subscale; HAS = Hamilton Anxiety Scale.  
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Table 2 
Estimates of temporal variation in experiential avoidance and anxiety symptoms across 
treatment from single-process univariate latent growth models 
Parameter estimate MEAQ MEAQ-DA HAS 
Intercept    
     Mean (SE) 214.67*** (2.65) 49.42*** (0.91) 17.26*** (0.67) 
     Variance (SE) 863.11*** (104.81) 104.47*** (12.39) 55.77*** (8.11) 
Slope     
     Mean (SE) -34.01*** (3.21) -9.78*** (0.92) -7.59*** (0.75) 
     Variance (SE) 958.27*** (187.53) 71.78*** (14.99) 36.07*** (9.67) 
Factor Loadings    
     Baseline 0.00 0.00 0.00 
     Session 4 0.14 0.35 0.16 
     Session 8 0.57 0.79 0.55 
     Session 12 0.84 0.89 0.73 
     Post-Tx 1.00 1.00 1.00 
Intercept-Slope    
     Covariance -143.48 -6.62 -29.18*** 
     Correlation -0.16 -0.08 -0.65*** 
Note. MEAQ = Multidimensional Experiential Avoidance Questionnaire; MEAQ-DA = 
Multidimensional Experiential Avoidance Questionnaire distress aversion subscale; HAS = 
Hamilton Anxiety Scale. Fit values for univariate growth models: MEAQ chi square = 9.24, p = 
.60, RMSEA = 0.00 (90% confidence interval [CI] = 0.00- 0.07, p = .84), TLI = 1.01, CFI = 
1.00; MEAQ-DA chi square = 30.10, p = .001, RMSEA = 0.11 (90% confidence interval [CI] = 
0.06 - 0.15, p = .02), TLI = 0.97, CFI = 0.97; HAS chi square = 18.46, p = .07, RMSEA = 0.06 
(90% confidence interval [CI] = 0.00- 0.11, p = .31), TLI = 0.97, CFI = 0.97.   
* p< .05, ** p< .01, *** p<.001 
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Table 3  
Completely standardized latent correlations from parallel-process latent growth curve models of 
experiential avoidance and symptoms of anxiety 
Construct HASINT HASSLP 
MEAQINT 0.25** -0.15 
MEAQ-DAINT 0.13 -0.16 
MEAQSLP -0.11 0.68*** 
MEAQ-DASLP -0.10 0.57*** 
Note. MEAQ = Multidimensional Experiential Avoidance Questionnaire; MEAQ-DA = 
Multidimensional Experiential Avoidance Questionnaire distress aversion subscale; HAS = 
Hamilton Anxiety Scale; INT = intercept; SLP = slope. Fit values for parallel process models: 
MEAQ and HAS χ2 = 61.67, p = .03, RMSEA = 0.05, (90% confidence interval [CI] = 0.02- 0.08, p 
= .49), TLI = 0.97, CFI = 0.97; MEAQ-DA and HAS χ2 = 83.90, p = < .001, RMSEA = 0.07, (90% 
confidence interval [CI] = 0.05- 0.10, p = .06), TLI = 0.96, CFI = 0.96. 
* p<.05, ** p< .01, *** p< .001 
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Table 4  
Satorra-Bentler scaled chi square difference scores and fit statistics for bivariate latent 
difference score models  
Index Both couplings MEAQ-DA to 
HAS only 
HAS to MEAQ-
DA only 
No coupling  
χ2/df  
 
77.34/44 78.04/45 82.82/45 82.62/46 
p .001 .002 <.001 <.001 
Satorra-Bentler 
Scaled χ2/Δdf  
 
-- 1.18/1 8.26/1 4.99/2 
p  .28 <.01 .08 
RMSEA .08 .08 .08 .08 
CI .05-.10 .05-.10 .05-.11 .05-10 
CFI .95 .96 .95 .95 
TLI .95 .96 .95 .95 
Overall fit 
significantly 
degraded? 
-- No Yes Trend 
Note. MEAQ-DA = Multidimensional Experiential Avoidance Questionnaire distress aversion 
subscale; HAS = Hamilton Anxiety Scale. RMSEA = root-mean-square error of approximation; 
CI = 90% confidence interval of the RMSEA; CFI = comparative fit index; TLI = Tucker Lewis 
index. 
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Figure 1. A bivariate latent difference score model of experiential avoidance (MEAQ) and anxiety (HAS) 
with couplings in both directions. ΔMEAQ[t] and ΔHAS[t] = latent change scores at time t. MEAQi and 
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HASi = initial scores. MEAQs and HASs = slopes. Triangle = constant.  α = slope parameter. β = 
autoproportional parameter. γ = coupling parameter. 
